Johnathan Lancaster

Johnathan Lancaster has joined Myriad Genetics as VP of Medical Affairs for Oncology, effective Feb. 9. He will provide medical and scientific leadership across the company's portfolio of molecular and companion diagnostic products and services for oncology. Lancaster will report to Lloyd Sanders, GM for the oncology business unit at Myriad Genetic Laboratories. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.